HCLTech AI Zone, TruAlt Bioenergy Funding, Small Caps Mixed Q4

HCL Technologies has launched an AI Innovation Zone in Chennai, aiming to accelerate enterprise AI adoption. Concurrently, TruAlt Bioenergy secured financial assistance of ₹150 crore under the Government of India’s PM JI-VAN Yojana.

These developments unfold as several small-cap firms reported a mixed Q4 March 2026 earnings season, with some facing significant sales declines and widening losses.

HCLTech Boosts AI Capabilities in Chennai

HCLTech’s new AI Innovation Zone in Chennai is designed to help enterprises operationalize Intel-based AI products and HCLTech AI solutions. The initiative focuses on accelerating the transition from AI experimentation to production-ready, cost-efficient deployments.

It features enterprise AI solutions powered by Intel Xeon 6 processors, underscoring a strategic push towards advanced AI integration.

TruAlt Bioenergy Secures Major Funding

TruAlt Bioenergy received approval for ₹150 crore in financial assistance. This funding is part of the PM JI-VAN Yojana, a government scheme supporting sustainable energy initiatives.

Small Caps Report Mixed Q4 2026 Results

The latest corporate earnings show a varied performance among smaller companies for the March 2026 quarter:

• Candour Techtex: Reported a profit after tax of ₹11.68 million. However, sales plunged 86.02% to ₹75.26 million year-over-year, despite operating profit growing to ₹32.58 million.
• Chandni Machines: Faced a net loss of ₹-11.53 million, a significant shift from a ₹1.55 million profit last year. Sales dramatically fell 99.86% to just ₹0.75 million, with operating profit margin slipping to -6.88%.
• CMX Holdings: Posted a net loss of ₹-2.24 million, widening from ₹-1.18 million in the prior year. The company’s operating profit margin further decreased to -1.23%.